News » Dispensary guidance news, England » Dydrogesterone 10mg tablets (Nalvee®) added to HRT PPC
September 2nd 2025
From 1 September 2025, Dydrogesterone 10mg tablets (Nalvee®) has been added to the list of medicines covered by the HRT prepayment certificate (HRT PPC).
This change has been reflected in Part XVI of the September 2025 Drug Tariff and on the NHSBSA has also updated its HRT medicines list
Other changes to Part XVI of the September 2025 Drug Tariff: Pfizer Limited recently ceased supplying Premarin® and Premique® Low Dose and has released generic equivalent versions instead. These generic versions are covered by the HRT PPC. For more information, see Community Pharmacy England's Drug Tariff Watch – September 2025.